Selenium Maleimide Cell Barcoding Without Spectral Overlap

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cell labeling and barcoding methods, such as mass cytometry, face limitations in parameterization due to spectral overlap and toxicity of reagents like ruthenium and osmium tetraoxide, and require pre-validation of antibodies for fixed epitope binding, restricting the number of parameters that can be determined and increasing toxicity risks.

Innovation Solution

Development of isotopically-pure selenium maleimide compounds that covalently react with cellular sulfhydryl groups, allowing for unique labeling of viable and fixed cells without spectral overlap and toxicity, enabling greater parameterization and deeper profiling capabilities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If ruthenium and osmium tetraoxide are used for cell labeling, then cell barcoding capability is achieved, but toxicity increases and handling becomes dangerous

Engineering Contradiction:
Improvecell barcoding capabilityVSAvoidtoxicity
Core Design Contradiction:
Adaptability or versatilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical identity of the labeling reagent from toxic ruthenium/osmium tetraoxide to less toxic selenium maleimide compounds, while maintaining the barcoding functionality through isotopic labeling of the selenium-containing compounds

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs disposable selenium maleimide compounds that can be used for single-use cell barcoding applications, eliminating the need for expensive and hazardous metal reagents while achieving the same multiplexing capability

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Productivity

If fixed cells are barcoded and pooled for antibody staining, then sample pooling efficiency improves, but staining of chemokine receptors is excluded

Engineering Contradiction:
Improvesample pooling efficiencyVSAvoidstaining capability
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The patent performs cell barcoding with selenium maleimide compounds before cell fixation and antibody staining, allowing subsequent staining of chemokine receptors on unfixed cells while maintaining the barcoding labels through the fixation process

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent separates the barcoding function from the staining function, allowing different subsets of cells to be stained with different antibodies while all cells retain their barcoding labels, enabling flexible experimental designs

Inventive Principle:
Principle #1Segmentation

3Quantity of substance

If fluorescently tagged antibodies are used in flow cytometry, then parameter detection is enabled, but spectral overlap limits the number of parameters

Engineering Contradiction:
Improvenumber of parametersVSAvoidspectral overlap
Core Design Contradiction:
Quantity of substanceVSDifficulty of detecting and measuring

Solution Approach 1:

The patent replaces the optical detection system of flow cytometry with mass cytometry detection, using selenium isotopes (76Se, 77Se, 78Se) that have distinct masses and no spectral overlap, enabling detection of many more parameters simultaneously

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the detection parameter from optical wavelength to mass-to-charge ratio, eliminating spectral overlap issues and enabling high-plex parameter detection with selenium-containing barcoding reagents

Inventive Principle:
Principle #35Parameter changes

4Adaptability or versatility

If isotope-tagged antibodies are used to label surface markers, then cell barcoding is achieved, but the number of available parameters is reduced

Engineering Contradiction:
Improvecell barcoding capabilityVSAvoidnumber of parameters
Core Design Contradiction:
Adaptability or versatilityVSQuantity of substance

Solution Approach 1:

The patent uses selenium maleimide compounds that can serve both as barcoding reagents and as universal labels for any cell type, freeing up antibody-based parameters for specific marker detection without competing for the same isotopic labels

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The selenium maleimide compounds effectively label cells with minimal channel spill, allowing for greater parameterization and deeper profiling without the need for antibodies, reducing toxicity and enabling uninterrupted instrument runs and improved data consistency.

Implementation Method 1

isotopically-pure selenium maleimide compounds that covalently react with cellular sulfhydryl groups

Methodology Applied
Scientific EffectCovalent bonding: Chemical Bonding

Data Source

PatentUS20240262818A1Selenium Maleimide Compounds And Uses Thereof
Publication Date: 2024.08.08 THE UNIV OF NORTH CAROLINA AT CHAPEL HILL
  • US20240262818A1 patent drawing
  • US20240262818A1 patent drawing
  • US20240262818A1 patent drawing

AI summary

The present disclosure relates to selenium containing compounds useful as cellular labeling and barcoding reagents, such as isotopically-pure selenium maleimide compounds and the use thereof.